Jones Financial Companies
CRDL

Jones Financial Companies’s Cardiol Therapeutics CRDL Stock Holding History

Jones Financial Companies’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Hold
19,847
– – ﹤0.01% 3210
2025
Q4 		$18.9K Sell
19,847
-1,213
-6% -$1.27K ﹤0.01% 2950
2025
Q3 		$22.7K Hold
21,060
– – ﹤0.01% 2729
2025
Q2 		$29.7K Hold
21,060
– – ﹤0.01% 2435
2025
Q1 		$20.2K Buy
21,060
+1,213
+6% +$1.49K ﹤0.01% 2429
2024
Q4 		$25.4K Buy
+19,847
New +$33.5K ﹤0.01% 2150

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jones Financial Companies's CRDL Position: Q1 2026 in Review

Jones Financial Companies held its Cardiol Therapeutics (CRDL) position steady in Q1 2026 at 19,847 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

Jones Financial Companies first reported a position in CRDL in Q4 2024 and has held it in 6 quarters since. The position peaked at $29.7K in Q2 2025. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Jones Financial Companies held 19,847 shares of Cardiol Therapeutics worth $24.8K as of Q1 2026.
  • Jones Financial Companies left its Cardiol Therapeutics share count unchanged in Q1 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3210 holding.
  • Jones Financial Companies first reported a position in Cardiol Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Cardiol Therapeutics position peaked at $29.7K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.